Suspected Necrotizing Soft Tissue Infection
Rapidly progressive infection with systemic toxicity
All Pathways
Infectious DiseaseEmergency
Necrotizing Soft Tissue Infection Management (IDSA 2014)
Necrotizing Soft Tissue Infection Management (IDSA 2014): Suspected Necrotizing Soft Tissue Infection → Clinical Features Suggestive of NSTI → Immediate...
Pathway Overview
15 steps
Algorithm Steps
15 total
01Start 02Action Clinical Features Suggestive of NSTI
High suspicion with any of these
- Pain out of proportion to exam findings
- Rapidly spreading erythema/induration
- Skin necrosis, hemorrhagic bullae
- Crepitus on palpation (gas in tissues)
- Systemic toxicity: Fever, tachycardia, hypotension
- Failure to respond to initial antibiotics
03Action Immediate Resuscitation
Hemodynamic stabilization
- IV access, fluid resuscitation
- Vasopressors if septic shock
- Blood cultures x2
- Labs: CBC, BMP, lactate, CK, CRP
- Type and screen for OR
04Decision Imaging Needed?
DO NOT delay surgery for imaging if high suspicion
- CT with contrast: Gas in soft tissues, fascial thickening
- MRI: Most sensitive but time-consuming
- Plain X-ray: May show gas
- IMAGING SHOULD NOT DELAY SURGERY
05Action EMERGENT Surgical Consultation
Surgery is the cornerstone of treatment
- Call surgery IMMEDIATELY - do not delay
- Surgical exploration is both diagnostic and therapeutic
- Findings: Dishwater gray necrotic fascia, lack of bleeding
- Positive finger test: Easy dissection along fascial planes
06Action Broad-Spectrum Empiric Antibiotics
Start immediately, before surgery
- Vancomycin 25-30mg/kg IV load, then 15-20mg/kg q8-12h
- PLUS Piperacillin-tazobactam 4.5g IV q6h (or Meropenem 1g q8h)
- PLUS Clindamycin 900mg IV q8h (toxin suppression)
- Alternative: Vancomycin + Ceftriaxone + Metronidazole + Clindamycin
07Decision NSTI Type Classification
Based on culture results and clinical context
08Action Type I: Polymicrobial
Mixed aerobic/anaerobic, often post-surgical or diabetic
- Continue broad coverage: Pip-tazo + Vancomycin + Clindamycin
- Covers: GNR, anaerobes, GPC
- Common in: Diabetes, peripheral vascular disease, post-op
- Fournier's gangrene typically Type I
09Action Aggressive Surgical Debridement
Repeat until margins clear
- Wide excision of all necrotic tissue
- Return to OR q24-48h for re-exploration
- Until healthy bleeding tissue margins
- May require fasciotomy, amputation in severe cases
- Wound VAC therapy between debridements
10Action ICU Level Care
Ongoing critical care support
- Hemodynamic monitoring and support
- Nutrition: High protein, enteral preferred
- Wound care team involvement
- Daily reassessment for further debridement
- Pain management
11Action Adjunctive Therapies
Consider in select cases
- IVIG: For streptococcal TSS (controversial)
- Hyperbaric oxygen: For clostridial myonecrosis
- Negative pressure wound therapy
- Reconstructive surgery after infection controlled
12Outcome Survival
Infection controlled, wound healing
- Mortality: 20-40% despite optimal treatment
- Earlier surgery = better outcomes
- Reconstructive surgery for wound closure
- Physical rehabilitation
13Warning Poor Prognosis
Delayed diagnosis, extensive disease
- Risk factors for death: Delayed surgery >24h, septic shock, diabetes, immunosuppression
- Truncal involvement worse than extremities
- Age >60 associated with higher mortality
14Action Type II: Monomicrobial (GAS)
Group A Streptococcus - most common cause
- Penicillin G 4 million units IV q4h
- PLUS Clindamycin 900mg IV q8h (suppresses toxin production)
- Can narrow from empiric therapy once culture confirmed
- Consider IVIG 1g/kg day 1, then 0.5g/kg days 2-3
- Path rejoins step 09Shared downstream outcome
15Action Type III: Clostridial (Gas Gangrene)
Clostridium perfringens/septicum
- Penicillin G 4 million units IV q4h
- PLUS Clindamycin 900mg IV q8h
- Consider hyperbaric oxygen therapy (if available)
- C. septicum: Consider occult GI malignancy
- Path rejoins step 09Shared downstream outcome
Guideline Source
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by IDSA
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Early diagnosis is challenging - high index of suspicion required
- LRINEC score has limited sensitivity - do not rely solely on it
- Surgical exploration is definitive diagnosis
- Polymicrobial vs monomicrobial affects antibiotic choice
- Mortality remains high (20-40%) even with optimal treatment
Applicable Regions
USEU
Version 1Next review: 2027-01-11
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Necrotizing Soft Tissue Infection Management (IDSA 2014)?
The Necrotizing Soft Tissue Infection Management (IDSA 2014) is a emergency clinical algorithm for Infectious Disease. It provides a structured decision tree to guide clinical decision-making, based on Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by IDSA.
What guideline is the Necrotizing Soft Tissue Infection Management (IDSA 2014) based on?
This algorithm is based on Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by IDSA (DOI: 10.1093/cid/ciu444).
What are the limitations of the Necrotizing Soft Tissue Infection Management (IDSA 2014)?
Known limitations include: Early diagnosis is challenging - high index of suspicion required; LRINEC score has limited sensitivity - do not rely solely on it; Surgical exploration is definitive diagnosis; Polymicrobial vs monomicrobial affects antibiotic choice; Mortality remains high (20-40%) even with optimal treatment. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Necrotizing Soft Tissue Infection Management (IDSA 2014) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free